Notice of Intent to Grant a Partially Exclusive Patent License; Sanofi Pasteur S.A., 42877 [E9-20363]
Download as PDF
Federal Register / Vol. 74, No. 163 / Tuesday, August 25, 2009 / Notices
Dated: August 19, 2009.
John M. Andersen,
Acting Deputy Assistant Secretary for
Antidumping and Countervailing Duty
Operations.
[FR Doc. E9–20500 Filed 8–24–09; 8:45 am]
BILLING CODE 3510–DS–S
DEPARTMENT OF DEFENSE
GENERAL SERVICES
ADMINISTRATION
NATIONAL AERONAUTICS AND
SPACE ADMINISTRATION
[FAR Case 2009–009; Docket 2009–0011,
Sequence 1]
Federal Acquisition Regulation; FAR
Case 2009–009, American Recovery
and Reinvestment Act of 2009 (the
Recovery Act)—Reporting
Requirements
Department of Defense (DoD),
General Services Administration (GSA),
and National Aeronautics and Space
Administration (NASA).
ACTION: Notice.
AGENCIES:
pwalker on DSK8KYBLC1PROD with NOTICES
SUMMARY: The Civilian Agency
Acquisition Council and the Defense
Acquisition Regulations Council (the
Councils) are issuing this notice to
inform Federal contractors that the
Recovery Accountability and
Transparency Board (‘‘Board’’) has
announced the availability of
registration at federalreporting.gov.
Federal contractors required to report on
their use of Recovery Act funds by FAR
clause 52.204–11 are encouraged to
register early.
DATES: Effective Date: August 25, 2009.
FOR FURTHER INFORMATION CONTACT: For
clarification of content, contact Mr.
Ernest Woodson, Procurement Analyst,
at (202) 501–3775. Please cite Notice to
Federal contractors on registration at
federalreporting.gov.
SUPPLEMENTARY INFORMATION:
A. Background
On March 31, 2009, the Councils
published an interim rule in the Federal
Register, FAR Case 2009–009, American
Recovery and Reinvestment Act of 2009
(the Recovery Act)—Reporting
Requirements (74 FR 14639). The rule
implements section 1512 of Public Law
111–5, the American Recovery and
Reinvestment Act of 2009 (the
‘‘Recovery Act’’), which requires
Federal contractors that receive awards
(or modifications to existing awards)
funded, in whole or in part, by the
Recovery Act to report quarterly on the
use of the funds at federalreporting.gov.
VerDate Nov<24>2008
22:52 Aug 24, 2009
Jkt 217001
To comply with the reporting
required by FAR 52.204–11, Federal
contractors must first register at
federalreporting.gov. Registration is now
open to Federal contractors. The
reporting tool will be available on
October 1, 2009. Reports, which are due
October 10, 2009, can only be submitted
once registration is authorized. For more
information on the registration and
authorization process, go to
federalreporting.gov. For information
regarding the Paperwork Reduction Act,
see Information Collection Request (ICR)
Reference Number 200907–0430–001
and OMB Control Number 0430–0002
available at https://www.reginfo.gov/
public/do/PRAMain (select ‘‘Recovery
Accountability and Transparency
Board’’ from the ‘‘Select Agency’’ drop
down menu and submit).
Dated: August 19, 2009.
David A. Drabkin,
Deputy Associate Administrator and Senior
Procurement Executive, Office of Acquisition
Policy.
[FR Doc. E9–20351 Filed 8–24–09; 8:45 am]
BILLING CODE 6820–EP–S
42877
zones and for travelers, including the
military.’’
DATES: Anyone wishing to object to the
grant of this license has fifteen (15) days
from the date of this notice to file
written objections along with
supporting evidence, if any. Written
objections are to be filed with the Office
of Technology Transfer, Naval Medical
Research Center, 503 Robert Grant Ave.,
Silver Spring, MD 20910–7500,
telephone (301) 319–7428.
ADDRESSES: Written objections are to be
filed with the Office of Technology
Transfer, Naval Medical Research
Center, 503 Robert Grant Ave., Silver
Spring, MD 20910–7500.
FOR FURTHER INFORMATION CONTACT: Dr.
Charles Schlagel, Director, Office of
Technology Transfer, Naval Medical
Research Center, 503 Robert Grant Ave.,
Silver Spring, MD 20910–7500,
telephone (301) 319–7428.
Dated: August 18, 2009.
A.M. Vallandingham,
Lieutenant Commander, Judge Advocate
General’s Corps, U.S. Navy, Federal Register
Liaison Officer.
[FR Doc. E9–20363 Filed 8–24–09; 8:45 am]
BILLING CODE 3810–FF–P
DEPARTMENT OF DEFENSE
Department of the Navy
Notice of Intent to Grant a Partially
Exclusive Patent License; Sanofi
Pasteur S.A.
AGENCY:
ACTION:
Department of the Navy, DOD.
Notice.
The Department of the Navy
hereby gives notice of its intent to grant
to Sanofi Pasteur S.A., a revocable,
nonassignable, partially exclusive
license to practice worldwide the
Government owned inventions
described in U.S. Patent Application
Serial No. 11/340,003 with inventor
Stephen J. Savarino filed on 10 January
2006, entitled ‘‘Adhesin as Immunogen
Against Enterotoxigenic E. coli’’ and its
related PCT/US2006/000660 National
Phase applications in Australia, Canada,
Europe, Japan and India filed 11 July
2007; and U.S. Patent Application Serial
No. 11/988,598 with inventors Stephen
J. Savarino, Randall K. Holmes and
Michael Jobling filed on 11 January
2007, entitled ‘‘Adhesin-Enterotoxin
Chimera Based Composition Against
Enterotoxigenic E. coli’’ and its related
PCT/US2007/000712 National Phase
applications in Australia, Canada,
Europe, and Japan filed 10 January 2008
in the field of ‘‘Protection against ETEC
(Enterotoxigenic Escherichia Coli)
associated diarrhea in both endemic
SUMMARY:
PO 00000
Frm 00036
Fmt 4703
Sfmt 4703
DEPARTMENT OF EDUCATION
Office of Elementary and Secondary
Education; Impact Aid Program—
American Recovery and Reinvestment
Act of 2009—Impact Aid Discretionary
Construction Program
ACTION: Notice inviting applications for
new awards under the American
Recovery and Reinvestment Act of
2009—Impact Aid Discretionary
Construction Program; Correction.
SUMMARY: On August 17, 2009, we
published in the Federal Register (74
FR 41407) a notice inviting applications
for new awards under the American
Recovery and Reinvestment Act of
2009—Impact Aid Discretionary
Construction Program. The notice
specified a deadline of October 1, 2009
for the submission of applications.
Since publication, however, we have
learned that the Department’s eApplication system will be shut down
on October 1 in connection with the
Department’s transition of its systems to
the new fiscal year, which begins on
October 1. Therefore, we are correcting
the deadline for the submission of
applications to October 8, 2009.
On page 41407, first column, the date
listed for Deadline for Transmittal of
Applications is corrected to read
‘‘October 8, 2009.’’ On page 41407, first
E:\FR\FM\25AUN1.SGM
25AUN1
Agencies
[Federal Register Volume 74, Number 163 (Tuesday, August 25, 2009)]
[Notices]
[Page 42877]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-20363]
-----------------------------------------------------------------------
DEPARTMENT OF DEFENSE
Department of the Navy
Notice of Intent to Grant a Partially Exclusive Patent License;
Sanofi Pasteur S.A.
AGENCY: Department of the Navy, DOD.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Department of the Navy hereby gives notice of its intent
to grant to Sanofi Pasteur S.A., a revocable, nonassignable, partially
exclusive license to practice worldwide the Government owned inventions
described in U.S. Patent Application Serial No. 11/340,003 with
inventor Stephen J. Savarino filed on 10 January 2006, entitled
``Adhesin as Immunogen Against Enterotoxigenic E. coli'' and its
related PCT/US2006/000660 National Phase applications in Australia,
Canada, Europe, Japan and India filed 11 July 2007; and U.S. Patent
Application Serial No. 11/988,598 with inventors Stephen J. Savarino,
Randall K. Holmes and Michael Jobling filed on 11 January 2007,
entitled ``Adhesin-Enterotoxin Chimera Based Composition Against
Enterotoxigenic E. coli'' and its related PCT/US2007/000712 National
Phase applications in Australia, Canada, Europe, and Japan filed 10
January 2008 in the field of ``Protection against ETEC (Enterotoxigenic
Escherichia Coli) associated diarrhea in both endemic zones and for
travelers, including the military.''
DATES: Anyone wishing to object to the grant of this license has
fifteen (15) days from the date of this notice to file written
objections along with supporting evidence, if any. Written objections
are to be filed with the Office of Technology Transfer, Naval Medical
Research Center, 503 Robert Grant Ave., Silver Spring, MD 20910-7500,
telephone (301) 319-7428.
ADDRESSES: Written objections are to be filed with the Office of
Technology Transfer, Naval Medical Research Center, 503 Robert Grant
Ave., Silver Spring, MD 20910-7500.
FOR FURTHER INFORMATION CONTACT: Dr. Charles Schlagel, Director, Office
of Technology Transfer, Naval Medical Research Center, 503 Robert Grant
Ave., Silver Spring, MD 20910-7500, telephone (301) 319-7428.
Dated: August 18, 2009.
A.M. Vallandingham,
Lieutenant Commander, Judge Advocate General's Corps, U.S. Navy,
Federal Register Liaison Officer.
[FR Doc. E9-20363 Filed 8-24-09; 8:45 am]
BILLING CODE 3810-FF-P